Latest filing published 23 Sept 2026 for BRIAPRO THERAPEUTICS CORP..
Insider track record
Martin Schmieg: trading record in brief
Filings by Martin Schmieg span 2 companies, the busiest being BriaCell Therapeutics Corp. and Briapro Therapeutics Corp. In total, 11 filings cover trades dated from 10 May 2016 to 7 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 23 September 2026, reports a share grant in Briapro Therapeutics Corp. Typically, a trade is published a median of 7 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Martin Schmieg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 359,000 sharesRestricted Stock UnitsTSXSEDI:4780849
- Restricted Stock UnitsTSXSEDI:4780846
- 45,000 sharesRestricted Share UnitsTSXSEDI:4748020
- 359,000 sharesCommon SharesTSXSEDI:4701070
- 34 sharesCommon SharesTSXSEDI:4567840
- 537 sharesCommon SharesTSXSEDI:4443692
- Common SharesTSXSEDI:4185563
- Common SharesTSXSEDI:3980503
- 100,000 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:3157687
- Common SharesTSXSEDI:3049736
- 72,391 shares@ CA$0.1655.7% of flowCommon SharesTSXSEDI:3049737
11 of 11 declarations
